Profiel
Renee T.
Leck is currently the Director of Investor Relations at Orchard Therapeutics Plc.
Previously, she worked as a Senior Manager of Investor Relations at Agios Pharmaceuticals, Inc. from 2015 to 2018.
Actieve functies van Renee T. Leck
Bedrijven | Functie | Begin |
---|---|---|
ORCHARD THERAPEUTICS PLC | Investor Relations Contact | - |
Eerdere bekende functies van Renee T. Leck
Bedrijven | Functie | Einde |
---|---|---|
AGIOS PHARMACEUTICALS, INC. | Public Communications Contact | 01-12-2018 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
AGIOS PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Orchard Therapeutics Plc
Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |